What is the address of MEDICAL INVESTMENT & CONSULTANCY?

The registered office of MEDICAL INVESTMENT & CONSULTANCY is located at Baron van Ertbornstraat 99, 2630 Aartselaar.

Is MEDICAL INVESTMENT & CONSULTANCY still active?

Yes. According to the CBE (2 November 2026) MEDICAL INVESTMENT & CONSULTANCY is active, legal situation “Normale toestand”, started on 24 March 2017.

Is MEDICAL INVESTMENT & CONSULTANCY registered on Peppol?

Yes, MEDICAL INVESTMENT & CONSULTANCY is registered on the Peppol network with ID 0208:0672995502.

What is the enterprise number of MEDICAL INVESTMENT & CONSULTANCY?

The enterprise number of MEDICAL INVESTMENT & CONSULTANCY is BE0672995502.

When was MEDICAL INVESTMENT & CONSULTANCY founded?

MEDICAL INVESTMENT & CONSULTANCY was founded on 24 March 2017.

Who are the directors of MEDICAL INVESTMENT & CONSULTANCY?

According to the 2025 annual accounts, the directors of MEDICAL INVESTMENT & CONSULTANCY are: Lars Herwyn.

Is MEDICAL INVESTMENT & CONSULTANCY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 March 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDICAL INVESTMENT & CONSULTANCY make in 2025?

MEDICAL INVESTMENT & CONSULTANCY posted a profit after taxes of € 166,246 in financial year 2025.

What is the revenue of MEDICAL INVESTMENT & CONSULTANCY?

As a small company, MEDICAL INVESTMENT & CONSULTANCY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 271,312.

MEDICAL INVESTMENT & CONSULTANCY (Private Limited)

Q: What does MEDICAL INVESTMENT & CONSULTANCY do?

MEDICAL INVESTMENT & CONSULTANCY is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 24 March 2017, 1 establishment.

Dossier MEDICAL INVESTMENT & CONSULTANCY, printed on 2 November 2026 from databakkes.be/en/0672995502/medical-investment-consultancy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDICAL INVESTMENT & CONSULTANCY from Aartselaar, company number BE0672995502, closed financial year 2025 with a result of € 166,246 after tax. For that financial year MEDICAL INVESTMENT & CONSULTANCY recorded a gross margin of € 271,312 and equity of € 235,497. Compared with financial year 2024, the result moved from € 43,193 to € 166,246. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.

What it is worth Growing

€ 235,497

▲ 163% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 166,246

▲ 285% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 133,921

▲ 219% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,253 paid out

12 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 18,747

▲ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 19 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 740,026

▼ 7% vs 2024

€ 39,246 is repaid this year. At this pace the long-term loan is gone in ≈ 19 years.

Owed to suppliers

€ 4,313

▼ 90% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,336

▼ 55% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 107,774 Gross margin 2022: € 107,774 First fiscal year in the series	€ 58,579 Gross margin 2023: € 58,579 ▼ 46% vs 2022 (€ 107,774) Unfavourable step	€ 100,975 Gross margin 2024: € 100,975 ▲ 72% vs 2023 (€ 58,579) Favourable step	€ 271,312 Gross margin 2025: € 271,312 ▲ 169% vs 2024 (€ 100,975) Favourable step	▲ 169%
Profit after taxes	€ -3,601 Profit after taxes 2022: € -3,601 First fiscal year in the series	€ 8,424 Profit after taxes 2023: € 8,424 ▲ € 12,025 vs 2022 (€ -3,601) Favourable step	€ 43,193 Profit after taxes 2024: € 43,193 ▲ € 34,769 vs 2023 (€ 8,424) Favourable step	€ 166,246 Profit after taxes 2025: € 166,246 ▲ 285% vs 2024 (€ 43,193) Favourable step	▲ 285%
Equity	€ 37,887 Equity 2022: € 37,887 First fiscal year in the series	€ 46,311 Equity 2023: € 46,311 ▲ 22% vs 2022 (€ 37,887) Favourable step	€ 89,504 Equity 2024: € 89,504 ▲ 93% vs 2023 (€ 46,311) Favourable step	€ 235,497 Equity 2025: € 235,497 ▲ 163% vs 2024 (€ 89,504) Favourable step	▲ 163%
Total debts	€ 1,035,356 Total debts 2022: € 1,035,356 First fiscal year in the series	€ 899,372 Total debts 2023: € 899,372 ▼ 13% vs 2022 (€ 1,035,356) Favourable step	€ 846,402 Total debts 2024: € 846,402 ▼ 6% vs 2023 (€ 899,372) Favourable step	€ 769,214 Total debts 2025: € 769,214 ▼ 9% vs 2024 (€ 846,402) Favourable step	▼ 9%
Cash	€ 39,236 Cash 2022: € 39,236 First fiscal year in the series	€ 2,807 Cash 2023: € 2,807 ▼ 93% vs 2022 (€ 39,236) Unfavourable step	€ 41,956 Cash 2024: € 41,956 ▲ € 39,149 vs 2023 (€ 2,807) Favourable step	€ 133,921 Cash 2025: € 133,921 ▲ 219% vs 2024 (€ 41,956) Favourable step	▲ 219%
Land & buildings	€ 948,713 Land & buildings 2022: € 948,713 First fiscal year in the series	€ 859,921 Land & buildings 2023: € 859,921 ▼ 9% vs 2022 (€ 948,713) Unchanged	€ 835,040 Land & buildings 2024: € 835,040 ▼ 3% vs 2023 (€ 859,921) Unchanged	€ 804,538 Land & buildings 2025: € 804,538 ▼ 4% vs 2024 (€ 835,040) Unchanged	▼ 4%
Retained profit	€ 19,287 Retained profit 2022: € 19,287 First fiscal year in the series	€ 27,711 Retained profit 2023: € 27,711 ▲ 44% vs 2022 (€ 19,287) Favourable step	€ 70,904 Retained profit 2024: € 70,904 ▲ 156% vs 2023 (€ 27,711) Favourable step	€ 216,897 Retained profit 2025: € 216,897 ▲ 206% vs 2024 (€ 70,904) Favourable step	▲ 206%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 20,253 Dividend 2025: € 20,253 Unchanged (€ 0) Unchanged
Bank debt	€ 831,793 Bank debt 2022: € 831,793 First fiscal year in the series	€ 817,706 Bank debt 2023: € 817,706 ▼ 2% vs 2022 (€ 831,793) Favourable step	€ 793,901 Bank debt 2024: € 793,901 ▼ 3% vs 2023 (€ 817,706) Favourable step	€ 740,026 Bank debt 2025: € 740,026 ▼ 7% vs 2024 (€ 793,901) Favourable step	▼ 7%
Balance sheet total	€ 1,073,243 Balance sheet total 2022: € 1,073,243 First fiscal year in the series	€ 945,683 Balance sheet total 2023: € 945,683 ▼ 12% vs 2022 (€ 1,073,243) Unchanged	€ 935,905 Balance sheet total 2024: € 935,905 ▼ 1% vs 2023 (€ 945,683) Unchanged	€ 1,004,711 Balance sheet total 2025: € 1,004,711 ▲ 7% vs 2024 (€ 935,905) Unchanged	▲ 7%

Key figures of MEDICAL INVESTMENT & CONSULTANCY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICAL INVESTMENT & CONSULTANCY?

What happened at MEDICAL INVESTMENT & CONSULTANCY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 8, 2026 New annual accounts for financial year 2025: profit of € 166,246 (▲ 285% vs 2024). Source: NBB ↗
Apr 1, 2017 New establishment in Aartselaar. KBO
2017 Lars Herwyn became a director. NBB
Mar 24, 2017 Start of the company according to the CBE. KBO

In short

From € 3,601 loss in 2022 to € 166,246 profit in 2025.

Paid € 73,905 in corporate taxes since 2022.

Best year ever: 2025, with € 166,246 profit.

Paid out € 20,253 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Lars Herwyn

MEDICAL INVESTMENT & CONSULTANCY

Behind MEDICAL INVESTMENT & CONSULTANCY is Lars Herwyn.

Directors

According to the 2025 annual accounts

Lars Herwyn

Director

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Baron van Ertbornstraat 99

2630 Aartselaar

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Medical Appliance Company

€ 366,819 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0672.995.502

VAT number

BE 0672.995.502

Registered office

Baron van Ertbornstraat 99, 2630 Aartselaar

Names & denominations

MEDICAL INVESTMENT & CONSULTANCY

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 March 2017

Peppol

Active · Active since 12 May 2025

Activities · NACE

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICAL INVESTMENT & CONSULTANCY

Financials

What happened to MEDICAL INVESTMENT & CONSULTANCY?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions